These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29771541)

  • 1. Plasmodial Kinase Inhibitors: License to Cure?
    Cabrera DG; Horatscheck A; Wilson CR; Basarab G; Eyermann CJ; Chibale K
    J Med Chem; 2018 Sep; 61(18):8061-8077. PubMed ID: 29771541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting malaria protein kinases.
    Cassiano GC; Tavella TA; Nascimento MN; Rodrigues DA; Cravo PVL; Andrade CH; Costa FTM
    Adv Protein Chem Struct Biol; 2021; 124():225-274. PubMed ID: 33632466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodial Kinase Inhibitors Targeting Malaria: Recent Developments.
    Mustière R; Vanelle P; Primas N
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33334080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases.
    Jirage D; Keenan SM; Waters NC
    Infect Disord Drug Targets; 2010 Jun; 10(3):134-46. PubMed ID: 20334624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting protein kinases in the malaria parasite: update of an antimalarial drug target.
    Zhang VM; Chavchich M; Waters NC
    Curr Top Med Chem; 2012; 12(5):456-72. PubMed ID: 22242850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.
    Moolman C; Sluis RV; Beteck RM; Legoabe LJ
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial drug discovery: targeting protein kinases.
    Doerig C; Meijer L
    Expert Opin Ther Targets; 2007 Mar; 11(3):279-90. PubMed ID: 17298288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
    Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
    J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical interrogation of the malaria kinome.
    Derbyshire ER; Zuzarte-Luís V; Magalhães AD; Kato N; Sanschagrin PC; Wang J; Zhou W; Miduturu CV; Mazitschek R; Sliz P; Mota MM; Gray NS; Clardy J
    Chembiochem; 2014 Sep; 15(13):1920-30. PubMed ID: 25111632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria: targeting parasite and host cell kinomes.
    Doerig C; Abdi A; Bland N; Eschenlauer S; Dorin-Semblat D; Fennell C; Halbert J; Holland Z; Nivez MP; Semblat JP; Sicard A; Reininger L
    Biochim Biophys Acta; 2010 Mar; 1804(3):604-12. PubMed ID: 19840874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges.
    Doerig C; Grevelding CG
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1637-43. PubMed ID: 25770683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes.
    Summers KL
    Mini Rev Med Chem; 2019; 19(7):569-590. PubMed ID: 30324878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring functional genomics for drug target and therapeutics discovery in Plasmodia.
    Birkholtz L; van Brummelen AC; Clark K; Niemand J; Maréchal E; Llinás M; Louw AI
    Acta Trop; 2008 Feb; 105(2):113-23. PubMed ID: 18083131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasite and host kinases as targets for antimalarials.
    Ong HW; Adderley J; Tobin AB; Drewry DH; Doerig C
    Expert Opin Ther Targets; 2023 Feb; 27(2):151-169. PubMed ID: 36942408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapies and future possibilities for drug development against liver-stage malaria.
    Raphemot R; Posfai D; Derbyshire ER
    J Clin Invest; 2016 Jun; 126(6):2013-20. PubMed ID: 27249674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.